This bill lowers the age at which minors in Washington, D.C. can be tried as adults for certain crimes from 16 to 14 years old. It amends two key sections of D.C. law: changing the age for exclusion from juvenile court jurisdiction (from 16 to 14) and lowering the age for transfer to criminal court (from 15-18 to 14 across multiple scenarios). The policy directly affects minors aged 14 or older who commit specified serious offenses in D.C., removing them from the juvenile justice system. The changes apply to offenses committed on or after the bill's effective date.
HR 4922, the DC Criminal Reforms to Immediately Make Everyone Safe Act of 2025 (DC CRIMES Act), modifies youth offender definitions and creates public transparency measures. It limits "youth offender" status to individuals 18 or younger (previously 24), removing provisions for 18-24 year olds in sentencing and facility planning. The bill requires the DC Attorney General to establish a public website publishing monthly juvenile crime statistics, including arrest data by age, race, sex, crime type, recidivism rates, and sentencing outcomes - without personally identifiable information. It also prohibits the DC Council from changing existing criminal sentencing laws. These provisions directly affect youth offenders aged 15-18 and DC government operations related to juvenile justice data.
This bill requires the Federal Protective Service to improve oversight of contract security guards protecting buildings owned or secured by the General Services Administration. It mandates standardized collection and analysis of covert testing data (simulated security breaches), quarterly reviews to identify recurring issues, and mandatory corrective training for guards who fail tests. The bill also directs an evaluation of the current personnel tracking system within 180 days, requiring a decision on replacement or upgrades with a public implementation plan. Annual reports to Congress will detail progress, system effectiveness, and tenant communication protocols for security coverage gaps.
This bill amends U.S. sanctions law to target Chinese entities and officials involved in fentanyl trafficking. It redefines "foreign opioid trafficker" to include Chinese chemical companies or government officials (like those in the National Narcotics Control Commission) that fail to prevent fentanyl precursor trafficking or cooperate with U.S. efforts. Key mechanisms include requiring China to implement stricter chemical shipment labeling and "know-your-customer" procedures, extending sanctions periods from 5 to 10 years, and mandating annual presidential reports to Congress on drug trafficking emergencies. The bill explicitly excludes importation of goods from sanctions coverage.
Halt All Lethal Trafficking of Fentanyl Act or the HALT Fentanyl Act This act permanently places fentanyl-related substances as a class into schedule I of the Controlled Substances Act. A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act. Under the act, offenses involving fentanyl-related substances are triggered by the same quantity thresholds and subject to the same penalties as offenses involving fentanyl analogues (e.g., offenses involving 100 grams or more trigger a 10-year mandatory minimum prison term). Additionally, the act establishes a new, alternative registration process for certain schedule I research. The act also makes several other changes to registration requirements for conducting research with controlled substances, including permitting a single registration for related research sites in certain circumstances, waiving the requirement for a new inspection in certain situations, and allowing a registered researcher to perform certain manufacturing activities with small quantities of a substance without obtaining a manufacturing registration. Finally, the act expresses the sense that Congress agrees with the interpretation of the Controlled Substances Act in United States v. McCray , a 2018 case decided by the U.S. District Court for the Western District of New York. In that case, the court held that butyryl fentanyl, a controlled substance, can be considered an analogue of fentanyl even though, under the Controlled Substances Act, the term controlled substance analogue specifically excludes a controlled substance.
HRES 405 is a procedural resolution that sets the rules for the House to debate and vote on three related bills. It waives objections and limits debate to one hour for H.R. 2240 (requiring reports on attacks against law enforcement), H.R. 2243 (amending officer safety laws and concealed carry rules), and H.R. 2255 (allowing federal officers to purchase retired service weapons). This resolution does not change the bills' content but streamlines their consideration process.
The HALT Fentanyl Act (HR 27) creates a new category of Schedule I controlled substances for "fentanyl-related substances" defined by specific chemical modifications to fentanyl. This law directly affects researchers, medical professionals, and law enforcement by expanding the legal definition of fentanyl-related substances to include many structurally similar compounds. Key provisions include streamlined registration processes for research on these substances, allowing researchers to conduct studies with expedited procedures if related to FDA-approved drug development or government-funded research. The bill requires the Attorney General to issue implementing rules within six months and includes penalties for violations involving these substances.
